193 related items for PubMed ID: 10583029
1. Short-term dose-response relationships for the relative systemic effects of oral prednisolone and inhaled fluticasone in asthmatic adults.
Wilson AM, Lipworth BJ.
Br J Clin Pharmacol; 1999 Oct; 48(4):579-85. PubMed ID: 10583029
[Abstract] [Full Text] [Related]
2. Effects of oral and inhaled corticosteroid on lymphocyte beta2-adrenoceptor function in asthmatic patients.
Tan KS, McFarlane LC, Lipworth BJ.
Br J Clin Pharmacol; 1997 Dec; 44(6):565-8. PubMed ID: 9431832
[Abstract] [Full Text] [Related]
3. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
Clark DJ, Lipworth BJ.
Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
[Abstract] [Full Text] [Related]
4. Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers.
Wilson AM, Clark DJ, McFarlane L, Lipworth BJ.
Eur J Clin Pharmacol; 1997 Jan; 53(1):33-7. PubMed ID: 9349927
[Abstract] [Full Text] [Related]
5. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients.
Casale TB, Nelson HS, Stricker WE, Raff H, Newman KB.
Ann Allergy Asthma Immunol; 2001 Nov; 87(5):379-85. PubMed ID: 11730179
[Abstract] [Full Text] [Related]
6. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.
Clark DJ, Grove A, Cargill RI, Lipworth BJ.
Thorax; 1996 Mar; 51(3):262-6. PubMed ID: 8779128
[Abstract] [Full Text] [Related]
7. Systemic bioactivity profiles of oral prednisolone and nebulized budesonide in adult asthmatics.
Wilson AM, McFarlane LC, Lipworth BJ.
Chest; 1998 Oct; 114(4):1022-7. PubMed ID: 9792571
[Abstract] [Full Text] [Related]
8. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
Lipworth BJ, Clark DJ, McFarlane LC.
Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
[Abstract] [Full Text] [Related]
9. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.
Lipworth BJ.
Arch Intern Med; 1999 May 10; 159(9):941-55. PubMed ID: 10326936
[Abstract] [Full Text] [Related]
10. Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults.
Wilson AM, Clark DJ, Devlin MM, McFarlane LC, Lipworth BJ.
Eur J Clin Pharmacol; 1998 Jan 10; 53(5):317-20. PubMed ID: 9516029
[Abstract] [Full Text] [Related]
11. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children.
Clark DJ, Clark RA, Lipworth BJ.
Thorax; 1996 Sep 10; 51(9):941-3. PubMed ID: 8984708
[Abstract] [Full Text] [Related]
12. Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler.
Dempsey OJ, Wilson AM, Coutie WJ, Lipworth BJ.
Chest; 1999 Oct 10; 116(4):935-40. PubMed ID: 10531156
[Abstract] [Full Text] [Related]
13. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
Harrison TW, Wisniewski A, Honour J, Tattersfield AE.
Thorax; 2001 Mar 10; 56(3):186-91. PubMed ID: 11182010
[Abstract] [Full Text] [Related]
14. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler.
Grahnén A, Jansson B, Brundin RM, Ling-Andersson A, Lönnebo A, Johansson M, Eckernäs SA.
Eur J Clin Pharmacol; 1997 Mar 10; 52(4):261-7. PubMed ID: 9248762
[Abstract] [Full Text] [Related]
15. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study.
Brutsche MH, Brutsche IC, Munawar M, Langley SJ, Masterson CM, Daley-Yates PT, Brown R, Custovic A, Woodcock A.
Lancet; 2000 Aug 12; 356(9229):556-61. PubMed ID: 10950233
[Abstract] [Full Text] [Related]
16. HPA-axis effects of nebulised fluticasone propionate compared with oral prednisolone in childhood asthma.
Price J, Lenney W, Duncan C, Green L, Flood Y, Daley-Yates P, Barnacle H, Efthimiou J.
Respir Med; 2002 Aug 12; 96(8):625-31. PubMed ID: 12195844
[Abstract] [Full Text] [Related]
17. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
Fowler SJ, Orr LC, Wilson AM, Sims EJ, Lipworth BJ.
Br J Clin Pharmacol; 2001 Jul 12; 52(1):93-5. PubMed ID: 11453895
[Abstract] [Full Text] [Related]
18. Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone.
Malo JL, Cartier A, Ghezzo H, Mark S, Brown J, Laviolette M, Boulet LP.
Eur Respir J; 1999 May 12; 13(5):993-8. PubMed ID: 10414395
[Abstract] [Full Text] [Related]
19. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
Derom E, Van Schoor J, Verhaeghe W, Vincken W, Pauwels R.
Am J Respir Crit Care Med; 1999 Jul 12; 160(1):157-61. PubMed ID: 10390394
[Abstract] [Full Text] [Related]
20. Dose response with fluticasone propionate on adrenocortical activity and recovery of basal and stimulated responses after stopping treatment.
Wilson AM, Sims EJ, Lipworth BJ.
Clin Endocrinol (Oxf); 1999 Mar 12; 50(3):329-35. PubMed ID: 10435058
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
